Menu
Back to Journals » International Journal of Nanomedicine » Volume 9 » Issue 1
Targeted nanotherapeutics in cancer
Authors Shiekh F
Received 15 February 2014
Accepted for publication 17 February 2014
Published 26 March 2014 Volume 2014:9(1) Pages 1627—1628
DOI https://doi.org/10.2147/IJN.S62468
Checked for plagiarism Yes
Farooq A Shiekh
Avalon University School of Medicine, Curaçao, Netherlands Antilles
Cancer is not one, but many heterogeneous diseases1 with complex genetic and epigenetic alterations2,3 that annually afflict millions of people worldwide. Despite the progress in understanding the molecular mechanics of cancer,4 its treatment has remained essentially unchanged and the death rates almost remain as they were 6 decades ago.5,6 In the past, the outstanding failure to deliver effective treatment to patients was a result of the inability to get enough of the right drug to the right place; however, the scenario has started to change substantially with the advent of new "targeted" cancer therapies.7–10
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.